Pelthos Therapeutics Inc.Pelthos Therapeutics Inc.Pelthos Therapeutics Inc.

Pelthos Therapeutics Inc.

No trades
See on Supercharts

About Pelthos Therapeutics Inc.


CEO
Scott M. Plesha
Headquarters
Durham
Founded
2021
FIGI
BBG01C9YP5V5
Pelthos Therapeutics, Inc. engages in the provision of therapeutic products. It produces products under its proprietary nitic oxide-based technology platform Nitricil. Its main product is a topical gel for the treatment of molluscum contagiosum. The company was founded on March 19, 2021 and is headquartered in Durham, NC.

Check out other big names from the same industry as PTHS.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of PTHS is 16.18 USD — it has decreased by −1.91% in the past 24 hours. Watch Pelthos Therapeutics Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on AMEX exchange Pelthos Therapeutics Inc. stocks are traded under the ticker PTHS.
PTHS stock has fallen by −86.05% compared to the previous week, the month change is a −84.59% fall, over the last year Pelthos Therapeutics Inc. has showed a −87.23% decrease.
PTHS stock is 28.23% volatile and has beta coefficient of 1.56. Track Pelthos Therapeutics Inc. stock price on the chart and check out the list of the most volatile stocks — is Pelthos Therapeutics Inc. there?
Yes, you can track Pelthos Therapeutics Inc. financials in yearly and quarterly reports right on TradingView.
No, PTHS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PTHS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Pelthos Therapeutics Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Pelthos Therapeutics Inc. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Pelthos Therapeutics Inc. stock shows the strong sell signal. See more of Pelthos Therapeutics Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.